APOTHEEK HELLINX
ActiveSummary
APOTHEEK HELLINX has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €262,385 and a net result of €6,772. Equity remains stable across the filed financial years (±1.4% per year). Its solvency ranks better than 40% of 5,034 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
- Staff
- 2.1 FTE
- Equity
- €262,385
- Profit
- €6,772
- Parent
- HELLINX · 98.4%
- DIERICKX PieterDirector
- HELLINX ChristelManaging director
Why 91raises riskSector: Retail trade (NACE 47)lowers riskFounded in 1987Liquidity: current ratio 1.73, cash €126,752Size: 2.1 FTE, total assets €946,302Show the evidence
Checked score
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 43% on solvency, 63% on liquidity, 51% on profitability and 47% on growth.
The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 8 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · full…
- Annual accounts filedfinancial year 2024 · abbreviated…
- Highest result from 2018 to 2025net €62,368 ▲58.5%
Financials · financial year 2025, full format
2025 annual accounts filed late (5 days) Filed on 5 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00384938.
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result falls in 2025; 2025 is 69% below 2024 and is the lowest result in the available series.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Average staff in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Peer companies
Historical observationOf the 3,984 companies that looked in July 2024 the way this one looks now, 1.1% went bankrupt within 24 months and 96.5% are still going.
- Micro
- 20 years or older
- solvency 10 to 30%
- a profit under 5% of the balance sheet
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 3,984 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | - | €107,573 | €135,115 | €130,922 | €122,348 | €146,224 | ▲ 19.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €4,011 | €56,213 | €64,756 | €68,215 | €67,574 | €67,648 | €64,068 | €62,805 | ▼ 2.0% |
| Other operating charges640/8 | - | - | - | €375 | €102 | €656 | €175 | €465 | ▲ 166% |
| Gross operating margin9900 | €148,836 | €187,335 | €184,196 | €210,779 | €236,548 | €251,182 | €264,122 | €233,531 | ▼ 11.6% |
| Operating profit (loss)9901 | €11,878 | €11,761 | -€11,656 | €34,616 | €33,758 | €51,956 | €77,531 | €24,036 | ▼ 69.0% |
| Financial income75/76B | - | - | - | €2 | €1 | €191 | €305 | €602 | ▲ 97.3% |
| Recurring financial income75 | €122 | €15 | €7 | €2 | €1 | €191 | €305 | €602 | ▲ 97.3% |
| Financial charges65/66B | - | - | - | €14,983 | €13,866 | €11,421 | €13,617 | €14,124 | ▲ 3.7% |
| Recurring financial charges65 | €3,938 | €14,125 | €15,942 | €14,983 | €13,866 | €11,421 | €13,617 | €14,124 | ▲ 3.7% |
| Profit (loss) for the period before taxes9903 | €8,062 | -€2,349 | -€27,590 | €19,635 | €19,893 | €40,726 | €64,219 | €10,514 | ▼ 83.6% |
| Income taxes67/77 | €165 | €55 | - | - | - | €1,380 | €1,851 | €3,742 | ▲ 102% |
| Profit (loss) for the period9904 | €7,897 | -€2,404 | -€27,590 | €19,635 | €19,893 | €39,346 | €62,368 | €6,772 | ▼ 89.1% |
| Profit (loss) for the period to be appropriated9905 | €7,897 | -€2,404 | -€27,590 | €19,635 | €19,893 | €39,346 | €62,368 | €6,772 | ▼ 89.1% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €0.5m | €1.3m | €1.2m | €1.2m | €1.1m | €1.0m | €1.0m | €0.9m | ▼ 2.7% |
| Fixed assets21/28 | €0.1m | €0.8m | €0.8m | €0.8m | €0.7m | €0.6m | €0.6m | €0.5m | ▼ 10.7% |
| Tangible fixed assets22/27 | €0.1m | €0.8m | €0.8m | €0.8m | €0.7m | €0.6m | €0.6m | €0.5m | ▼ 10.8% |
| Land and buildings22 | - | - | - | €0.4m | €0.4m | €0.4m | €0.4m | €0.4m | ▼ 3.2% |
| Plant, machinery and equipment23 | - | - | - | €0.4m | €0.3m | €0.3m | €0.2m | €0.2m | ▼ 23.8% |
| Furniture and vehicles24 | - | - | - | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | ▼ 25.8% |
| Financial fixed assets28 | - | €0.005m | €0.005m | €0.005m | €0.005m | €0.005m | €0.005m | €0.005m | = |
| Current assets29/58 | €0.4m | €0.5m | €0.4m | €0.4m | €0.4m | €0.4m | €0.4m | €0.4m | ▲ 9.4% |
| Stocks and contracts in progress3 | €0.09m | €0.1m | €0.1m | €0.1m | €0.1m | €0.1m | €0.2m | €0.2m | ▲ 4.4% |
| Stocks30/36 | - | - | - | €0.1m | €0.1m | €0.1m | €0.2m | €0.2m | ▲ 4.4% |
| Amounts receivable within one year40/41 | €0.1m | €0.1m | €0.08m | €0.07m | €0.09m | €0.08m | €0.1m | €0.1m | ▲ 10.1% |
| Trade receivables40 | - | - | - | €0.07m | €0.09m | €0.08m | €0.1m | €0.1m | ▲ 10.0% |
| Other amounts receivable41 | - | - | - | €0.001m | €0.002m | €0.001m | €0 | €89 | - |
| Cash at bank and in hand54/58 | €0.2m | €0.3m | €0.1m | €0.2m | €0.1m | €0.1m | €0.1m | €0.1m | ▲ 20.6% |
| Deferred charges and accrued income490/1 | - | - | - | €0.02m | €0.03m | €0.03m | €0.02m | €0.02m | ▼ 10.7% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €0.5m | €1.3m | €1.2m | €1.2m | €1.1m | €1.0m | €1.0m | €0.9m | ▼ 2.7% |
| Equity10/15 | €0.2m | €0.2m | €0.2m | €0.2m | €0.3m | €0.3m | €0.3m | €0.3m | ▲ 2.6% |
| Contributions10/11 | €0.06m | €0.06m | €0.06m | €0.06m | €0.06m | €0.06m | €0.06m | €0.06m | = |
| Capital10 | - | - | - | €0.06m | €0.06m | €0.06m | €0.06m | €0.06m | = |
| Issued capital100 | - | - | - | €0.06m | €0.06m | €0.06m | €0.06m | €0.06m | = |
| Reserves13 | €0.09m | €0.09m | €0.09m | €0.09m | €0.09m | €0.09m | €0.09m | €0.09m | = |
| Non-distributable reserves130/1 | - | - | - | €0.006m | €0.006m | €0.006m | €0.006m | €0.006m | = |
| Legal reserve130 | - | - | - | €0.006m | €0.006m | €0.006m | €0.006m | €0.006m | = |
| Distributable reserves133 | - | - | - | €0.08m | €0.08m | €0.08m | €0.08m | €0.08m | = |
| Profit (loss) carried forward14 | €0.09m | €0.09m | €0.06m | €0.08m | €0.1m | €0.1m | €0.1m | €0.1m | ▲ 6.4% |
| Amounts payable17/49 | €0.3m | €1.1m | €1.0m | €0.9m | €0.8m | €0.8m | €0.7m | €0.7m | ▼ 4.6% |
| Amounts payable after more than one year17 | €0.09m | €0.8m | €0.7m | €0.7m | €0.6m | €0.6m | €0.5m | €0.4m | ▼ 12.3% |
| Financial debts170/4 | - | - | - | €0.7m | €0.6m | €0.6m | €0.5m | €0.4m | ▼ 12.3% |
| Amounts payable within one year42/48 | €0.2m | €0.3m | €0.3m | €0.3m | €0.2m | €0.2m | €0.2m | €0.2m | ▲ 12.6% |
| Current portion of amounts payable after more than one year42 | - | - | - | €0.06m | €0.06m | €0.06m | €0.06m | €0.06m | ▲ 1.4% |
| Trade debts44 | €0.1m | €0.2m | €0.1m | €0.1m | €0.1m | €0.06m | €0.06m | €0.09m | ▲ 46.7% |
| Suppliers440/4 | - | - | - | €0.1m | €0.1m | €0.06m | €0.06m | €0.09m | ▲ 46.7% |
| Taxes, remuneration and social security45 | - | - | - | €0.02m | €0.02m | €0.03m | €0.02m | €0.03m | ▲ 30.0% |
| Taxes450/3 | - | - | - | €279 | €0.001m | €0.003m | €0.003m | €0.002m | ▼ 24.6% |
| Remuneration and social security454/9 | - | - | - | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | ▲ 38.5% |
| Other amounts payable47/48 | - | - | - | €0.04m | €0.02m | €0.05m | €0.08m | €0.07m | ▼ 9.1% |
| Accrued charges and deferred income492/3 | - | - | - | €0.001m | €0.001m | €0.001m | €0.001m | €0.002m | ▲ 56.2% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €7,897 | -€2,404 | -€27,590 | €19,635 | €19,893 | €39,346 | €62,368 | €6,772 | ▼ 89.1% |
| + Depreciation and write-downs630 | €4,011 | €56,213 | €64,756 | €68,215 | €67,574 | €67,648 | €64,068 | €62,805 | ▼ 2.0% |
| Operating cash flow (approximation) | €11,908 | €53,809 | €37,166 | €87,850 | €87,467 | €106,994 | €126,436 | €69,577 | ▼ 45.0% |
| Investment in fixed assets (approximation) | - | -€745,445 | -€101,698 | -€10,946 | -€2,939 | €0 | -€2,232 | €0 | - |
| Change in cash | - | €61,845 | -€126,315 | €38,230 | -€65,486 | -€3,244 | -€2,424 | €21,672 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 38 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | full format | 05-08-2026 | 2026-00384938 |
| 31-12-2024 | abbreviated format | 08-08-2025 | 2025-00367627 |
| 31-12-2023 | abbreviated format | 05-08-2024 | 2024-00327290 |
| 31-12-2022 | abbreviated format | 21-07-2023 | 2023-00258062 |
| 31-12-2021 | abbreviated format | 16-08-2022 | 2022-20288869 |
| 31-12-2020 | abbreviated format | 19-08-2021 | 2021-49800542 |
| 31-12-2019 | abbreviated format | 10-08-2020 | 2020-39900247 |
| 31-12-2018 | abbreviated format | 24-07-2019 | 2019-36500587 |
| 31-12-2017 | abbreviated format | 30-07-2018 | 2018-39100570 |
| 31-12-2016 | abbreviated format | 02-08-2017 | 2017-39700202 |
Similar companies · same sector, comparable size
Subsidies and aid
Flemish government
2022 · 1 entry · €105 awarded · €105 paidPublic contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Board 2
Day-to-day management 1
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Day-to-day management
- began earlier
| Name | Functions and periods |
|---|---|
| DIERICKX Pieter |
|
| HELLINX Christel |
|
Owners and capital
Owners
1 ownerChain of control
- HELLINX
- APOTHEEK HELLINX
Highest known parent: HELLINX. The sources do not say who stands above it.
Owners 1
- HELLINXparentSourceaccounts HELLINX 202598.4%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- 21-11-2023 Capital stated in the deed · €62,000 · 125 shares
Group and network
Connections & network
2 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
Acts, filings and financial milestones
21-11
Gazette deed
Resignations: HELLINX Christel (director) and DIERICKX Pieter (director)Appointments: HELLINX Christel (director) and DIERICKX Pieter (director) · Permanent representative: HELLINX Christel · Amendment of the articles12 facts ▸
- General meeting, “buitengewone algemene vergadering van de aandeelhouders, APOTHEEK HELLINX” (deed in Dutch)
- Amendment of the articles (3 times)
- Capital, €62,000
- Registered office clause, “2260 Westerlo,Grote Markt 56” (deed in Dutch)
- Other provision, “website en e-mailadres” (deed in Dutch)
- Director resignation, HELLINX Christel (director)
- Director resignation, DIERICKX Pieter (director)
- Board rule, “eenparigheid van stemmen”, 2 (deed in Dutch)
- Director appointment, HELLINX Christel (director)
- Director appointment, DIERICKX Pieter (director)
- Permanent representative, HELLINX Christel (2 times)
- Director appointment, HELLINX Christel (enige afgevaardigde bestuurder)
About the unread acts
Of the 6 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 31 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Recognitions · licences · registrations
Food safety, FASFC
1 siteEnvironmental permits
Source: Omgevingsloket Vlaanderen. Flanders only: Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 13049B0530/00H000 | Flanders | 717 m² | 1 · 346 m² | 12.2 m · 1 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Het verlenen van advies in verband met beheer en management van ondernemingen; De uitbating van één of meerdere apotheken,; De…” (deed in Dutch)
9 activities (deed in Dutch)
- Het verlenen van advies in verband met beheer en management van ondernemingen.
- De uitbating van één of meerdere apotheken,
- De groothandel,de aan en verkoop,de bereiding van alle:
- Scheikundige,farmaceutische,para farmaceutische,phytfarmaceutische producten
- Veeartsenij- en drgisterijproducten,specialiteiten,
- Csmetica en hygiënische producten,waaronder begrepen zijn:
- Parfumerie,dieetproducten,natuurvoeding enzovoorts,zonder enige beperking.
- De aan- en verkoop alsmede de reparaties van alle gezichts- en gehoorapparaten en aanverwante artikelen.
- De aan- en verkoop en de handel in alle soorten materialen en voorwerpen van bandagisten en orthopedisten.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Apotheek Hellinx
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “Artikel 20: Vertegenwoordiging van de vennootschap • De raad van bestuur vertegenwoordigt de vennootschap jegens derden en in rechte als…”
- Board ruleHow the board is made up, meets and takes decisions.
- “Raad van bestuur, keuze bestuursmodel” (deed in Dutch)“Statutenwijziging, wijziging bestuursmodel” (deed in Dutch)“Samenstelling raad van bestuur, herstemming tussen twee meeste stemmen” (deed in Dutch)“Voorzitterschap, raad kiest voorzitter uit midden” (deed in Dutch)“Bijeenroeping raad, telkens belang vennootschap vereist” (deed in Dutch)“Voorstel verworpen, bijzondere volmacht aan collega per vergadering” (deed in Dutch)“Alle handelingen nodig of dienstig tot verwezenlijking voorwerp, bevoegdheden raad” (deed in Dutch)“Enige bestuurder, enige bestuurder samenstelling en bevoegdheid” (deed in Dutch)“Vergoeding enige bestuurder, andersluidend besluit algemene vergadering” (deed in Dutch)1 more provision on this in the deed
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Saturday of May at 20:00